Healthcare

XYNTHA Solofuse Now Available in Canada for Patients with Hemophilia A

KIRKLAND, QUEBEC: XYNTHA Solofuse brings to Canadian patients a new way to reconstitute their recombinant factor VIII, without a transfer step, all in one syringe. XYNTHA Solofuse also offers a new 3000 IU dosage stren ...

Second Parathyroid Hormone (PTH) Peptide Drug Patent Awarded to Aegis Therapeutics for Compositions Suitable for Metered Nasal Spray, Oral, and Injectable Delivery

SAN DIEGO, CA: ...

Ekso Bionics Bestowed With CE Mark

BERKELEY, CA: Sales of Its Bionic Suit "Ekso" Fuel International Expansion ...

BIOTRONIK's Bioabsorbable Magnesium Scaffold Continues to Show Strong Results at 12 Months With Uncompromised Device Usability

BUELACH, SWITZERLAND: ...

Bio-Rad Named One of the '2012 Best Places to Work' in the San Francisco Bay Area

HERCULES, CA: ...

CNIB: Most Eye Injuries Can Be Prevented

TORONTO, ONTARIO: ...

LeukoDx Receives Third Year Chief Scientist Grant for 50% of $1.15 Million R&D Budget

JERUSALEM: LeukoDx Is Developing a Small Table Top Device That Provides Rapid Diagnostic Information for Early Detection of Blood Infections ...

Life Sciences M&A Values Soar in 2011

SAN FRANCISCO, CA: Weak IPO Market Helps Fuel Trend Among Private Companies to Turn to Acquisitions for Exits, According to Burrill & Company's New Book ...

FDA Grants Fast Track Designation to Ohr Pharmaceutical's Squalamine Eye Drops for the Treatment of Wet-AMD

NEW YORK, NY: Expects to Commence Phase II Clinical Trial in Third Quarter 2012 ...

$75,000 2012 CARO-Elekta Research Fellowship Awarded to Dr. Kathy Han for Cervical Cancer Study

OTTAWA, ONTARIO: ...